Research and Markets: China In Vitro Diagnostics Market Outlook to 2018 – Clinical Chemistry Genetic Testing …

Posted: January 9, 2013 at 9:45 am

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/hd2zhs/china_in_vitro) has announced the addition of GlobalData's new report "China In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

Our new report, China In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the China In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.

- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the China In Vitro Diagnosticsmarket.

- Key players covered include Siemens Healthcare, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Shanghai Kehua Bio-engineering Co., Ltd., Beckman Coulter, Inc. and others.

Reasons to buy

Visit link:
Research and Markets: China In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing ...

Related Posts

Comments are closed.

Archives